These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30981754)

  • 1. The Degradation Chemistry of Prasugrel Hydrochloride: Part 1-Drug Substance.
    Baertschi SW; Maxwell-Backer L; Clemens M; Smitka TA; Draper JR; Taylor KW; Kaerner A; Jansen PJ
    J Pharm Sci; 2019 Sep; 108(9):2842-2857. PubMed ID: 30981754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the forced degradation behavior of prasugrel hydrochloride by liquid chromatography with mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products.
    Singh DK; Sahu A; Handa T; Narayanam M; Singh S
    J Sep Sci; 2015 Sep; 38(17):2995-3005. PubMed ID: 26114771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and Structural Elucidation of an Unknown Impurity in Prasugrel by Semi-Preparative Liquid Chromatography.
    Liu C; Yu Z; Wang F; Zhong X; Jiang L; Zhang F; Tang Y; Yan Z; Zeng S; Pu T
    J Chromatogr Sci; 2015 Aug; 53(7):1163-8. PubMed ID: 25644811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC method for determination of prasugrel and mass spectrometry detection for thermal and alkaline degradation products.
    Rigobello C; Barden AT; Steppe M
    Pharmazie; 2015 Aug; 70(8):515-21. PubMed ID: 26380520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive forced degradation studies of Cariprazine hydrochloride using LC-HRMS/MS and in silico toxicity predictions of its degradation products.
    Jain M; Khan S
    J Pharm Biomed Anal; 2022 Sep; 219():114955. PubMed ID: 35917732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of degradation products of amorphous and polymorphic forms of clopidogrel bisulphate under solid state stress conditions.
    Raijada DK; Prasad B; Paudel A; Shah RP; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):332-44. PubMed ID: 19520540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced Oxidative Degradation Pathways of the Imidazole Moiety of Daclatasvir.
    Huang Y; Su BN; Marshall J; Miller SA
    J Pharm Sci; 2019 Oct; 108(10):3312-3318. PubMed ID: 31145924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive study to identify and characterize major degradation products of Ivermectin drug substance including its degradation pathways using LC-HRMS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 May; 214():114730. PubMed ID: 35334396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the Degradation Chemistry of the Antitumor Agent Pemetrexed Disodium.
    Jansen PJ; Smith WK; Baertschi SW; Dorman DE; Kemp CAJ; McCune KA
    J Pharm Sci; 2016 Nov; 105(11):3256-3268. PubMed ID: 27539558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the major degradation pathways of ticagrelor.
    Sadou Yayé H; Secrétan PH; Henriet T; Bernard M; Amrani F; Akrout W; Tilleul P; Yagoubi N; Do B
    J Pharm Biomed Anal; 2015 Feb; 105():74-83. PubMed ID: 25543285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Degradation Chemistry of Farglitazar and Elucidation of the Oxidative Degradation Mechanisms.
    Reynolds DW; Campbell JM; Johnson BS; Joshi BK; Facchine KL; Long S; O'Connell TM; Paulus IV; Sides SL; Kraft ES; Wolters AM
    J Pharm Sci; 2017 Apr; 106(4):982-993. PubMed ID: 27988163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
    Bansal G; Singh R; Saini B; Bansal Y
    J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prasugrel Hydrochloride.
    Al Omari MM; Qinna NA; Rashid IS; Al-Sou'od KA; Badwan AA
    Profiles Drug Subst Excip Relat Methodol; 2015; 40():195-320. PubMed ID: 26051687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation and characterization of forced degradation products in homoharringtonine injection by UHPLC-Q-TOF-MS.
    Gu X; Chen Y; Lou Y; Zheng J
    J Pharm Biomed Anal; 2019 Nov; 176():112801. PubMed ID: 31430625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of degradation products of midazolam maleate by UHPLC-HR-IT-MS
    Feng X; Du G; Hou T; Liu X; Chao R
    Pharmazie; 2017 Feb; 72(2):73-80. PubMed ID: 29441856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil.
    Mehta S; Shah RP; Priyadarshi R; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):345-54. PubMed ID: 19505786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.